Cargando…
Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium
Despite promising findings, quantitative PCR (qPCR)-based tests for RNA quantification have experienced serious limitations in their clinical application. The noticeable lack of technical standardization remains a huge obstacle in the translation of qPCR-based tests. The incorporation of qPCR-based...
Autores principales: | de Gonzalo-Calvo, David, Marchese, Monica, Hellemans, Jan, Betsou, Fay, Skov Frisk, Nanna Lond, Dalgaard, Louise Torp, Lakkisto, Päivi, Foy, Carole, Scherer, Andreas, Garcia Bermejo, María Laura, Devaux, Yvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792405/ https://www.ncbi.nlm.nih.gov/pubmed/35118162 http://dx.doi.org/10.1016/j.omtm.2021.12.007 |
Ejemplares similares
-
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
por: Gomes, Clarissa Pedrosa da Costa, et al.
Publicado: (2019) -
A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease
por: Robinson, Emma Louise, et al.
Publicado: (2020) -
Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Frisk, Nanna Lond Skov, et al.
Publicado: (2023) -
Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis
por: Dinesen, Sofie, et al.
Publicado: (2023) -
Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129
por: Vanhaverbeke, Maarten, et al.
Publicado: (2021)